capecitabine has been researched along with Inflammatory Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corral de la Fuente, E; Fernández Abad, M; Martin Huertas, R; Martínez Jáñez, N; Serrano Domingo, JJ | 1 |
| Kumar, PV; Prabaharan, S; Ravind, R | 1 |
2 other study(ies) available for capecitabine and Inflammatory Breast Cancer
| Article | Year |
|---|---|
Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Female; Fluorouracil; Humans; Inflammatory Breast Neoplasms; Lapatinib; Neoplasm Recurrence, Local; Receptor, ErbB-2; Trastuzumab; Treatment Outcome | 2020 |
Inflammatory breast cancer in a previously treated case of breast cancer: a diagnostic dilemma for the clinician.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Female; Humans; Inflammatory Breast Neoplasms; Lapatinib; Middle Aged; Neoplasms, Second Primary; Paclitaxel; Prognosis; Quinazolines | 2016 |